COEP (Coeptis Therapeutics Holdings) Other Stockholders Equity: $-3.69 Mil (As of Dec. 2025)


COEP Coeptis Therapeutics Holdings Inc COEP
12 GF Score
Price $16.40
View Full Analysis

What is Coeptis Therapeutics Holdings Other Stockholders Equity?

Coeptis Therapeutics Holdings COEP +1.52% 12 Other Stockholders Equity is $-3.69 Mil as of Dec. 2025. GuruFocus rates COEP with a GF Score™ of 12/100.

Coeptis Therapeutics Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-3.69 Mil.

Coeptis Therapeutics Holdings's quarterly Other Stockholders Equity declined from Jun. 2025 ($0.23 Mil) to Sep. 2025 ($-2.10 Mil) and declined from Sep. 2025 ($-2.10 Mil) to Dec. 2025 ($-3.69 Mil).

Coeptis Therapeutics Holdings's annual Other Stockholders Equity increased from Dec. 2023 ($-3.50 Mil) to Dec. 2024 ($-1.56 Mil) but then declined from Dec. 2024 ($-1.56 Mil) to Dec. 2025 ($-3.69 Mil).

Coeptis Therapeutics Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Coeptis Therapeutics Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coeptis Therapeutics Holdings Other Stockholders Equity Chart

Coeptis Therapeutics Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.00 -3.50 -1.56 -3.69

Coeptis Therapeutics Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.56 -0.25 0.23 -2.10 -3.69
COEP
12GF Score
Coeptis Therapeutics Holdings Inc COEP
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coeptis Therapeutics Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-3.69 Mil mean?
Coeptis Therapeutics Holdings (COEP) has a Other Stockholders Equity of $-3.69 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Coeptis Therapeutics Holdings and its competitors.
Is Coeptis Therapeutics Holdings' Other Stockholders Equity too high?
Coeptis Therapeutics Holdings' current Other Stockholders Equity is $-3.69 Mil. Overall, Coeptis Therapeutics Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Coeptis Therapeutics Holdings' Other Stockholders Equity compare to ANIX and COYA?
Coeptis Therapeutics Holdings' Other Stockholders Equity of $-3.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Coeptis Therapeutics Holdings and its competitors. Coeptis Therapeutics Holdings's current Other Stockholders Equity is $-3.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coeptis Therapeutics Holdings stock overvalued right now?
Coeptis Therapeutics Holdings (COEP) has a current Other Stockholders Equity of $-3.69 Mil. The current Other Stockholders Equity is $-3.69 Mil. Coeptis Therapeutics Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Coeptis Therapeutics Holdings (COEP), the current Other Stockholders Equity is $-3.69 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coeptis Therapeutics Holdings Business Description

Address 105 Bradford Road, Suite 420, Wexford, PA, USA, 15090
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
12GF Score

Get the complete analysis for COEP

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.40
Price